Bicocca Open Archive

Logo unimib boa
PUOTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.851
AS - Asia 13.465
EU - Europa 7.043
SA - Sud America 2.230
AF - Africa 325
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 36.934
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.999
SG - Singapore 5.109
VN - Vietnam 2.399
HK - Hong Kong 2.180
CN - Cina 1.873
RU - Federazione Russa 1.753
BR - Brasile 1.711
IT - Italia 1.404
SE - Svezia 781
IE - Irlanda 778
DE - Germania 711
CA - Canada 655
FR - Francia 389
IN - India 312
GB - Regno Unito 290
BD - Bangladesh 255
ID - Indonesia 229
AT - Austria 205
AR - Argentina 194
KR - Corea 185
FI - Finlandia 175
IQ - Iraq 154
UA - Ucraina 137
TR - Turchia 128
NL - Olanda 126
MX - Messico 119
EC - Ecuador 102
PK - Pakistan 96
ZA - Sudafrica 93
JP - Giappone 79
ES - Italia 74
SA - Arabia Saudita 71
PH - Filippine 66
CO - Colombia 54
UZ - Uzbekistan 54
PL - Polonia 49
VE - Venezuela 43
PY - Paraguay 37
MA - Marocco 34
TN - Tunisia 32
KE - Kenya 31
EG - Egitto 30
MY - Malesia 28
ET - Etiopia 27
CL - Cile 25
JO - Giordania 24
PE - Perù 24
CZ - Repubblica Ceca 22
OM - Oman 22
AE - Emirati Arabi Uniti 21
UY - Uruguay 19
DZ - Algeria 18
NP - Nepal 18
BO - Bolivia 17
CR - Costa Rica 17
IL - Israele 17
IR - Iran 17
LB - Libano 17
JM - Giamaica 16
KZ - Kazakistan 16
LT - Lituania 15
BE - Belgio 14
AZ - Azerbaigian 13
TH - Thailandia 13
CH - Svizzera 12
BG - Bulgaria 11
DK - Danimarca 11
DO - Repubblica Dominicana 11
GR - Grecia 11
KG - Kirghizistan 11
PT - Portogallo 11
AL - Albania 10
PS - Palestinian Territory 10
AU - Australia 9
HN - Honduras 8
HU - Ungheria 8
NG - Nigeria 8
PA - Panama 8
SN - Senegal 8
BH - Bahrain 7
BY - Bielorussia 7
KW - Kuwait 7
RO - Romania 7
TW - Taiwan 7
CI - Costa d'Avorio 6
GH - Ghana 6
MU - Mauritius 6
MD - Moldavia 5
NI - Nicaragua 5
AO - Angola 4
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
KH - Cambogia 4
LY - Libia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CG - Congo 3
Totale 36.868
Salva come PNG Salva come JPEG
Città #
Singapore 2.902
Hong Kong 2.156
Ann Arbor 1.097
Ashburn 1.095
San Jose 1.092
Dublin 769
Ho Chi Minh City 736
Fairfield 593
Hanoi 589
New York 557
Toronto 521
Chandler 479
Chicago 434
Houston 421
Frankfurt am Main 420
The Dalles 399
Hefei 393
Woodbridge 386
Princeton 382
Santa Clara 374
Dallas 372
Los Angeles 344
Milan 305
Wilmington 293
Lauterbourg 247
Seattle 229
Beijing 224
Cambridge 197
Altamura 193
Lawrence 187
Council Bluffs 179
Seoul 176
Buffalo 169
Moscow 167
Jakarta 160
São Paulo 148
Jacksonville 117
Nuremberg 117
Vienna 113
San Diego 111
Dearborn 103
Rome 90
Shanghai 84
Helsinki 83
Haiphong 80
Da Nang 77
Tokyo 69
Andover 64
London 64
Orem 64
Baghdad 61
Salt Lake City 52
Tashkent 52
Munich 49
Rio de Janeiro 47
Biên Hòa 45
Dong Ket 45
Lappeenranta 42
Nanjing 42
Guangzhou 41
Ha Long 41
Denver 38
Brooklyn 37
Montreal 37
Atlanta 35
Hải Dương 35
Quito 35
Elk Grove Village 34
Tampa 34
Warsaw 34
Chennai 33
Guayaquil 33
Johannesburg 33
Quận Bình Thạnh 33
Dhaka 32
Phoenix 32
Amsterdam 31
Falls Church 30
Lahore 30
Curitiba 29
Mumbai 29
Brasília 28
Lachine 28
New Delhi 28
Belo Horizonte 27
Boardman 27
Hangzhou 27
Jeddah 27
Ninh Bình 27
Stockholm 27
Bologna 24
Kent 24
Vũng Tàu 24
Columbus 23
Porto Alegre 23
Erbil 22
Mexico City 22
Nairobi 22
Norwalk 22
Turku 22
Totale 22.276
Salva come PNG Salva come JPEG
Nome #
Sexually Transmitted Hepatitis 456
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons 376
24-Hour Blood Pressure Monitoring Patterns in HIV-Positive Patients and its Relationship with Arterial Distensibility 359
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 319
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 315
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 291
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 285
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 272
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 266
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: Results from the Icona Foundation study 256
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 255
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 249
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 249
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 248
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 247
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 244
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy 239
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons 237
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 234
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 234
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 233
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 228
Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program 224
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study 224
Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis c coinfection: Data from the ICONA foundation cohort 218
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 215
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 214
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 214
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 210
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 209
Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study 209
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 208
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 206
Multiple concomitanti infezioni opportunistiche e linfomi aggressivi in una persona con HIV/AIDS che non assumeva la terapia ant 205
24 HOUR ARTERIAL DISTENSIBILITY IS RELATED WITH ABPM NON-DIPPING PATTERN IN HIVPOSITIVE PATIENTS 204
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy 204
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 201
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 200
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients 199
Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis [Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne] 198
COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study 198
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 196
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi 195
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 195
24-hours arterial distensibility is related with ABPM non-dipping pattern in HIV-positive patients 195
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 193
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection 193
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 189
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence study 189
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 189
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 187
Factors Influencing Depression Endpoints Research (FINDER): Baseline results of Italian patients with depression 187
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 186
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy 186
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 183
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 183
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement 182
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons 182
HIV-positive to HIV-positive liver transplantation: To be continued 181
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 180
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 180
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients 179
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 177
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 177
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection 175
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 175
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 173
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 171
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 169
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration 169
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults 169
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference 168
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation 165
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 165
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 164
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 164
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 163
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients 161
Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients 161
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014 160
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 160
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals 158
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 157
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study) 155
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 155
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience 154
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV 153
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 153
Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: Results from a cross-sectional survey on 7,014 workers in healthcare 153
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 151
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy) 151
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic 150
HEFFICON: HIV effectiveness Italian conference 150
Prophylaxis and treatment of hepatitis B in immunocompromised patients 150
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 148
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 148
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969–1989 birth-cohort 147
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 147
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 147
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 145
Totale 20.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 0 0 0 0 0 0 204 167
2021/20221.849 73 108 269 174 85 120 44 273 125 101 89 388
2022/20232.627 467 752 231 174 113 433 24 140 165 24 71 33
2023/20242.592 55 63 79 70 344 600 445 55 297 48 101 435
2024/20258.480 516 1.159 431 382 664 341 418 216 899 1.270 819 1.365
2025/202618.375 2.454 1.745 1.474 1.905 1.981 939 2.577 977 1.446 1.607 1.270 0
Totale 37.922